ARA-290 vs TB-500
TB-500, a synthetic version of thymosin beta-4's active fragment, promotes tissue regeneration through effects on cell migration and angiogenesis. It works more systemically than BPC-157. TB-500 Nerve protection, anti-inflammation Whole-tissue regeneration Sco
This comparison does not assign a generated winner or score.
- TB-500, a synthetic version of thymosin beta-4's active fragment, promotes tissue regeneration through effects on cell migration and angiogenesis.
- It works more systemically than BPC-157.
- TB-500
- Nerve protection, anti-inflammation
- Whole-tissue regeneration
- Scope
- Neurovascular-focused
- Systemic, cardiovascular, muscle
- Angiogenesis
- Via IRR activation
- Directly increases VEGF production
- Neuropathy, inflammatory conditions
- General recovery, muscle injury
- Subcutaneous daily
- Subcutaneous 2x weekly typically
- TB-500's strengths lie in general tissue regeneration and recovery. ARA-290's strengths lie specifically in nerve protection and inflammation control. For conditions involving both nerve damage and tissue injury, using both might provide complementary benefits.